Stomach Cancer Market Size, Share and Growth Outlook 2030
市场洞察和分析师观点:
胃癌,又称胃癌,是由于胃癌的异常和失控生长引起的。胃中的恶性细胞。导致胃癌风险的危险因素包括年龄和食物。消化不良、胃部不适、食欲不振、胃灼热和体重减轻都是胃癌的症状。治疗胃癌采用不同的方法,例如化疗、放射治疗和免疫治疗。胃癌市场的增长受到多种因素的影响,例如胃癌发病率不断上升、治疗方法的进步(包括化疗、手术和靶向治疗)以及为改善患者治疗效果而进行的持续研发工作。随着人们越来越重视早期诊断和个性化治疗方法,预计未来胃癌治疗市场将继续扩大。
增长动力:
医疗保健市场的企业正在开展各种研发活动,以引入胃癌的创新治疗方法。此外,治疗方法正在临床试验中进行评估,新的方法也正在通过临床试验不断开发和研究。部分正在研发的产品如下:
2022年12月,浙江多尔生物制品有限公司与默克公司签订临床试验合作协议,评估多尔生物的抗Claudin18。 2 抗体 DR30303 与默沙东的抗 PD-1 疗法 KEYTRUDA(pembrolizumab)联合治疗胃癌或胃食管交界癌患者。根据协议条款,Doer Bio 根据双方商定并最终确定的方案进行了一项实验研究,以调查 DR30303 联合 KEYTRUDA 在 Claudin18.2 阳性、局部晚期不可切除或转移性胃或胃食管交界处的安全性和有效性2022 年 11 月,Triumvira Immunologics 公布了其在研 TAC-T 细胞疗法 CLDN18.2-TAC T 和 GUCY2C-TAC T 的临床前数据,以及 HER2 特异性 TAC-T 产品的数据。该公司展示了其新型 T 细胞抗原偶联剂 (TAC)-靶向 Claudin 18.2 治疗胃癌的 T 细胞候选药物的最新数据。 2022 年 9 月,Nuvectis Pharma, Inc. 宣布 NXP800 在 ARID1a- 临床前异种移植模型中的阳性数据突变的胃癌。每组小鼠接受载体或 NXP800 治疗后,测量肿瘤体积 28 天。与对照组相比,NX800治疗的结果是肿瘤消退和显着的肿瘤生长抑制。因此,越来越多的临床试验有助于提高全球范围内胃癌治疗的可用性,进而对胃癌的生长产生积极影响市场。
报告细分和范围:
胃癌市场根据类型、治疗、给药途径、分销渠道和地理位置进行细分。根据类型,胃癌市场分为腺癌、胃肠道间质瘤、神经内分泌肿瘤、淋巴瘤等。根据治疗方法,胃癌市场分为靶向和免疫治疗药物、化疗和联合药物等。胃癌市场按给药途径分为口服、肠胃外和其他。从分销渠道来看,胃癌市场分为医院药房、零售药房和网上药房。从地理上看,胃癌市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利和欧洲其他地区)、亚太地区(中国、印度、日本、澳大利亚、韩国以及亚太其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
细分分析:
胃癌市场按类型分为腺癌、胃肠道间质瘤、神经内分泌肿瘤、淋巴瘤等。腺癌细分市场在 2022 年占据了很大的市场份额,预计 2022 年至 2030 年胃癌市场的复合年增长率最高。
按类型划分的胃癌市场 – 2022 年和 2030 年
基于治疗,胃癌市场分为靶向和免疫治疗药物、化疗和联合药物等。 2022年,化疗和联合用药领域占据了重要的市场份额。预计2022-2030年靶向和免疫治疗药物领域的复合年增长率最高。
根据给药途径,胃癌市场分为口服、肠胃外和其他。 2022年,口服药占据了相当大的市场份额,预计2022-2030年将创下最快的复合年增长率。
根据分销渠道,胃癌市场分为医院药房、零售药房和药房。网上药店。医院药房细分市场在 2022 年占据重要市场份额,预计 2022 年至 2030 年复合年增长率最高。
区域分析:
胃癌市场主要分为北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。 2022 年,北美占据了很大的市场份额。 2022年,美国占据该地区最大的市场份额。北美市场的增长归因于胃癌患病率的不断上升、靶向癌症治疗的不断采用以及癌症研究和治疗中心先进技术的可及性。美国癌症协会预计,2023 年将诊断出约 26,500 例新胃癌病例(男性 15,930 例,女性 10,570 例)。约 11,130 例死亡(男性 6,690 例,女性 4,440 例)将死于胃癌。北美在减少癌症的先进技术治疗方案的可及性方面非常发达,企业正在努力与该地区的知名企业竞争。
此外,公司在开展临床试验方面的活动不断增加开发针对胃癌患者的有效药物以及增加产品上市和批准预计将推动该地区的市场增长。 2021年4月,美国食品和药物管理局(FDA)批准百时美施贵宝的Opdivo联合氟嘧啶和含铂化疗药物,用于治疗晚期或转移性胃癌和食管腺癌患者。因此,这些因素可能会在预测期内支持该地区的市场增长。
行业发展和未来机遇:
下面列出了全球胃癌市场主要参与者采取的众多举措:
2021年1月,阿斯利康和第一三共公司的Enhertu获得美国FDA批准,用于治疗晚期或转移性HER2阳性胃腺癌成人患者。竞争格局和主要公司:
百时美施贵宝公司;诺华公司;默克公司;礼来公司;比奥康;梯瓦制药工业有限公司;赛尔群医疗保健有限公司;三星Bioepis;辉瑞公司;和 Ipsen Pharma 是胃癌市场的知名参与者。这些公司专注于推出新的高科技产品、现有产品的进步以及地域扩张,以满足全球不断增长的消费者需求。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The adenocarcinomas segment dominated the global stomach cancer market and held the largest market share of 45.34% in 2022.
The stomach cancer market majorly consists of the players such include Novartis AG, Pfizer, Inc., Mylan N.V., F. Hoffmann La Roche Ltd., Eli Lilly and Company, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Celltrion Healthcare Co., Ltd., Samsung Bioepis and Bristol Myers Squibb Company.
Stomach cancer is one of the leading causes of cancer-related deaths and the fifth most common malignancy worldwide. According to Globocan, around 1.1 million new cases of the disease were diagnosed worldwide in 2020. The increase in disease burden and approval of pipeline candidates are anticipated to propel the growth of the market during the forecast period.
The CAGR value of the stomach cancer market during the forecasted period of 2020-2030 is 14.76%
Global stomach cancer market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the stomach cancer market in 2022.
Increasing lifestyle changes such as smoking and alcoholism, an increase in obesity, and an increasing prevalence of gastroesophageal reflux disease all act as risk factors for gastric cancer.
The List of Companies - Stomach Cancer Market
- Bristol Myers Squibb Company
- Novartis AG
- Merck & Co., Inc.
- Eli Lilly and Company
- Biocon
- Teva Pharmaceutical Industries Ltd.
- Celltrion Healthcare Co., Ltd.
- Samsung Bioepis
- Pfizer Inc.
- Ipsen pharma.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.